Pharmafile Logo

Medical affairs – a strategic function for scientific engagement

The shift in dynamics between medical affairs and commercial teams

- PMLiVE

David Youds, CEO, Bedrock Group

The function of Medical Affairs has evolved over the years, and continues to do so at quite a pace. The traditional dynamic between Medical Affairs and Commercial teams has been one of restriction, with regulations on “promotional” activities. However, in more recent times there has been a shift towards an increasingly shared responsibility between Commercial and Medical Affairs teams based on mutual values of patient centricity, value propositions and the use of data.

Medical Affairs has always been a vital conduit of information both inwards and outwards. Partnerships between Medical Affairs and external stakeholders are invaluable and provide insights that can steer future medical strategy. The increasing focus of these external stakeholders on proactive communication  has driven Medical Affairs teams to be more forward-looking and ensure a greater understanding of the needs and preferences of their internal and external audiences.

As a result of these shifting dynamics, and in a world with better informed audiences than ever before, the scope of deliverables, availability of new technology and the relative size of medical budgets has changed. Correspondingly, strategic input from Medical Affairs is in demand now more than ever.

As has been said many times “with great power comes great responsibility”. There is increasing responsibility for Medical Affairs to be proactive, address data gaps, be patient-focused, creative, understand channel choice, and deliver behaviour change in addition to their more traditional role in medical and scientific information. This means new skills and new internal partnerships are required.

Most importantly, Medical Affairs needs to assert itself as a strategic co-leader of any pharmaceutical product. There are too many examples of sub-optimal collaboration between commercial and medical departments, often blamed on compliance and the need for ‘firewalls’. While an element of this argument holds true, with the right mindset in place and an early start on strategic alignment across internal functions, many of these barriers can be overcome. The value of this collaborative approach for health systems, and ultimately patients, is huge.

David Youds, CEO, Bedrock Group

www.bedrock-health.com / www.origins-insights.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Bedrock Group celebrates a trio of new hires

Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.

This isn't goodbye, it's see you in August!

Bedrock Group imagines, creates and delivers industry-leading benefits

SIGHT project team wins top recognition award

SIGHT project team scoops the Bedrock Group CEO Team Award 2019

How 2019 ignited my passion for insights

Stacey East, Insights Manager, Origins, shares her learnings from the Pharma Market Research Conference

Meg Morgan wins top recognition award

Meg scoops the Bedrock Group’s CEO 2019 Award

Bedrock’s on fire for Wellbeing Week

Bedrock creates a positive working environment to enable individuals and our business to thrive.

Insights from non-healthcare marketing: Brand Activism – does it have a role in Pharma?

Increasingly consumers are demanding that brands be more active – that they not only stand for something, but they do something about it.

Rewarding Long Service at Bedrock

Katie Penfold celebrates 5 years with the Bedrock Group

Bedrock are in the Top 3

Bedrock named No. 3 Young Agency by PMLive

When it’s OK to not be OK: Bedrock breaks down mental health stigma

As part of Bedrock’s Wellbeing Programme, Bedrock paired up with Simpila to talk about mental health challenges and open up about the pressures we all face, both in and out...